secwatch.observer — SEC 8-K summary
======================================

Issuer:     CG Oncology, Inc. (CGON)
CIK:        0001991792
Form:       8-K
Filed at:   2026-04-13T23:59:59+00:00
Accession:  0001193125-26-152044
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CG Oncology appoints Jim DeTore as CFO with $520K base and $5M equity
---------------------------------------------------------------------

- Jim DeTore, age 61, appointed CFO effective April 13, 2026; previously served as interim principal financial officer since Nov 2025.
- Initial annual base salary of $520,000 with target bonus of 45% of base salary.
- Equity grants: $4M stock option (4-year vest, 25% one-year cliff) and $1M PSU award (vesting on first U.S. commercial sale and positive operating cash flow).
- Severance includes 12 months base salary and COBRA for non-CIC terminations; 1.5x base salary and full vesting for CIC terminations.
- DeTore reports to CEO and will work remotely from Boston area.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1991792/000119312526152044/0001193125-26-152044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1991792/000119312526152044/ck0001991792-20260413.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-152044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer